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The detection and diagnosis of the opportunistic fungi Scedosporium spp. and
Lomentospora prolificans still relies mainly on low-sensitive culture-based methods.
This fact is especially worrying in Cystic Fibrosis (CF) patients in whom these fungal
species are frequently isolated and may increase the risk of suffering from an infection or
other health problems. Therefore, with the purpose of developing a serologic detection
method for Scedosporium/Lomentospora, four different Scedosporium boydii protein
extracts (whole cell protein extract, secretome, total cell surface and conidial surface
associated proteins) were studied by ELISA to select the most useful for IgG detection in
sera from CF patients. The four extracts were able to discriminate the Scedosporium/
Lomentospora-infected from Aspergillus-infected and non-infected patients. However,
the whole cell protein extract was the one selected, as it was the one with the highest
output in terms of protein concentration per ml of fungal culture used, and its
discriminatory capacity was the best. The ELISA test developed was then assayed with
212 sera from CF patients and it showed to be able to detect Scedosporium spp. and
Lomentospora prolificans with very high sensitivity and specificity, 86%–100% and 93%–
99%, respectively, depending on the cut-off value chosen (four values were proposed
A450nm= 0.5837, A450nm= 0.6042, A450nm= 0.6404, and A450nm= 0.7099). Thus, although
more research is needed to reach a standardized method, this ELISA platform offers a
rapid, low-cost and easy solution to detect these elusive fungi through minimally invasive
sampling, allowing the monitoring of the humoral response to fungal presence.
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In recent years huge efforts have been made to develop new
serological techniques to improve diagnosis of fungal infections.
However, most of the advances are focused on high prevalence
fungal pathogens such as Aspergillus or Candida. Regarding less
common fungi like Scedosporium/Lomentospora, which are
considered emerging pathogens and are gaining clinical
relevance due to the severity of the infections they cause, there
are no commercial detection methods available. This manuscript
describes an ELISA test developed using a whole cell protein
extract from Scedosporium boydii that offers a great sensitivity
and specificity to detect Scedosporium/Lomentospora in Cystic
Fibrosis (CF) patients using serum samples. Compared with the
commercial kits for other fungi, which usually show a 75%–96%
of sensitivity, the clinical usefulness of the test developed is
remarkable considering that values obtained are of 86%–100%
for sensitivity and 93%–99% for specificity. These results place it
in a good position as a candidate to be used as a diagnostic tool.
Thus, this ELISA platform is a rapid, low-cost, and easy solution
to detect Scedosporium/Lomentospora, allowing the monitoring
of the antifungal humoral response.INTRODUCTION
Cystic fibrosis (CF) is the major genetic disorder among the
Caucasian population (Mirtajani et al., 2017). This multisystem
disease is caused by mutations in the CFTR (Cystic Fibrosis
Transmembrane Conductance Regulator) gene encoding a
chloride-conducting transmembrane channel, which participates
in electrolytic transport and mucociliary clearance of the airways.
CFTR dysfunction results in an increased viscosity of secretions
and underlies an altered immune response of these patients (Rowe
et al., 2005). Although several organs are adversely affected,
morbimortality is essentially associated with lesions in the lungs
(Castellani & Assael, 2017). The airways of CF patients are affected
by the accumulation of a thick layer of sticky bronchial mucus,
which acts as a culture media for microorganisms, entrapping
airborne bacteria and fungal spores, immobilizing them and
facilitating their growth. In this sense, these pathogens cause
chronic respiratory infections, turning the lung into an
inflammatory microenvironment and eventually leading to
pulmonary damage (Elborn, 2016).
Even though bacteria, such as Pseudomonas aeruginosa or
Staphylococcus aureus, are known to be the major causative
agents of these infections, several fungal species colonize the
respiratory tract of CF patients. However, while the relevance of
bacteria is well known, the clinical significance of fungal recovery
from respiratory secretions remains unclear (Schwarz et al., 2018).
Candida albicans, among yeasts, andAspergillus fumigatus, among
filamentous fungi, are the fungal species most frequently isolated
from CF respiratory samples. However, fungi from Scedosporium
genus are increasingly reported in theCFcontext andcurrently rank
second, just behind A. fumigatus, among the filamentous fungi
colonizing CF airways (LiPuma, 2010).Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2Despite airway colonization by Scedosporium spp., or the
strongly related Lomentospora prolificans (Ramirez-Garcia et al.,
2018), it is usually well tolerated, it may lead to a true respiratory
infection with variable degree of tissue invasion, fungal
sensitization or allergic bronchopulmonary mycoses (Martín-
Gómez, 2020). In fact, these fungal pathogens seems to be more
representative during scenarios of moderate-to-severe alteration
of lung function, and their presence on CF airways has been
associated with a decline in Forced Expiratory Volume in 1 s
(FEV1) (Soret et al., 2020). In addition, the chronic detrimental
presence of these pathogens may cause fatal disseminated
infections when the patient undergoes an immunosuppression
period, for example after a lung transplantation (Symoens
et al., 2006).
Unfortunately, lung infection or colonization by Scedosporium/
Lomentospora is nowadays a diagnostic and therapeutic challenge
in CF patients. Despite the many methods of Aspergillus detection
being currently available, the detection of Scedosporium/
Lomentospora relies upon low sensitivity culture-based
traditional methods. Recently, some advances have been made
on molecular diagnosis, but these methodologies are not
standardized and not accessible to everyone, and serodiagnosis
strategies are performed only in specialized laboratories, but these
are not commercially available (Mina et al., 2017). Therefore, the
precise diagnosis of these fungi is actually a significant challenge.
Furthermore, the clinical features and histopathology of infected
tissue samples are similar to those of aspergillosis, so confirmation
data of these species may often be underestimated (Mello et al.,
2019). Hence, detection and correct discrimination of
Scedosporium infections from others is of crucial importance
because the treatments may be quite different. Indeed,
Scedosporium/Lomentospora species are considered intrinsically
resistant to most of the currently available antifungal drugs (Pellon
et al., 2018).
In this sense, to contribute to the finding of new diagnostic
weapons that allow prevention, early diagnosis, and ultimately a
more effective treatment, our research group analysed different
protein extracts of Scedosporium boydii as serodiagnostic tools to
detect Scedosporium/Lomentospora and discriminate them from
other fungal pathogens relevant in the CF context. Therefore, in
this study we designed and tested a customized serological assay
for the detection of Scedosporium-specific IgG antibodies in sera
from CF patients.MATERIALS AND METHODS
Microorganisms and Culture Conditions
The fungal strains used in this study were Scedosporium boydii
CBS 116995, Lomentospora prolificans CECT 20842, Aspergillus
fumigatus Af293 and Candida albicans NCPF 3153. All strains
were maintained cryopreserved at -80ºC and cultured as required
on Potato Dextrose Agar (PDA) (Pronadisa, Madrid, Spain).
To harvest conidiospores of S. boydii and L. prolificans, PDA
plates grown at 37ºC for 7 dayswerewashed twicewith sterile saline
solution (0.9% [w/v] NaCl) (SS). The suspension of conidia wasNovember 2020 | Volume 10 | Article 602089
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Conidia of A. fumigatus were collected from PDA tubes grown at
37ºC for 4 days using sterile SS-Tween20 (0.9% [w/v] NaCl, 0.02%
[v/v] Tween20), and washed twice by centrifugation. Finally, C.
albicans was grown in PDA tubes at 37ºC for 24 h, and yeast cells
were gathered next day by resuspending the culture with phosphate
buffered saline (PBS). The concentration of each fungal cell was
adjusted as needed using a hemocytometer.
Human Serum Sample Collection and
Categorization
A collection of 212 sera from CF patients (corresponding to 102
different patients) were used in this study with the approval of
the Ethics Committee from the University of the Basque Country
(UPV/EHU; reference M30/2018/081).
The categorization of the sera was based on the results of
mycological examination of a sputum sample collected in parallel
to the sera and inoculated on Sabouraud gentamicin
chloramphenicol agar, and simultaneously on Modified Thayer
Martin agar or Sabouraud chloramphenicol agar supplemented
with0.5 g/L cycloheximide for the specific recoveryofScedosporium
species from these polymicrobial samples.All plateswere incubated
at 37ºC for up to 15 days before to consider the sputum samples as
free of fungi. According to these, three groups of sera were defined:
Group Scedo+ (n = 23) consisted of sera from CF patients with
positive cultures forScedosporium/Lomentospora, GroupAsp+(n=
86), CF patients with Aspergillus spp. being the only filamentousFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3fungi recovered from sputum; and group Scedo-/Asp- (n = 103) as
control, consisted of sera fromCFpatients without anyfilamentous
fungus recovered from samples. Sera from patients with co-
infection of Scedosporium/Lomentospora and Aspergillus spp.
were included in the group Scedo+.
In addition, five sera from each group described above were
selected to evaluate the usefulness of different protein extracts for
Scedosporium/Lomentospora serodiagnosis, and to study cross-
reactivity with other fungal pathogens. To do that, two criteria
were followed: each serum corresponded to a different patient
without any coinfections.
Fungal Protein Extracts
Four different protein extracts were obtained for this study:
whole cell protein extract (Total WCP), extract of secreted
proteins (Secretome), cell surface associated proteins (Total
CSP) and conidial surface proteins (Conidial CSP). All extracts
were obtained for S. boydii, but the Total WCP was also obtained
for L. prolificans, A. fumigatus, and C. albicans. The resulting
protein extracts were stored at -80ºC until required.
The extraction processes (Figure 1)were carried out in triplicate
and the quality of the extract was verified by SDS-PAGE in 12%
polyacrylamide gels, stained afterwards as previously described
(Dyballa and Metzger, 2009) with Coomassie Brilliant Blue G250
(CBB), and digitalized using ImageScanner III (GE Healthcare,
Chicago, IL, USA). Protein concentration was quantified using
Pierce 660 nm Protein Assay Reagent (Thermo Fisher Scientific,FIGURE 1 | Workflows employed for obtaining S. boydii protein extracts. Key-steps in the obtaining of crude total extract (Total WCP), secretome, total extract of
cell-surface associated proteins (Total CSP) and conidial cell-surface associated proteins (Conidial CSP) of S. boydii.November 2020 | Volume 10 | Article 602089
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reagents present in the extraction buffers, protein extracts were
precipitated with a solution of acetone and 10% (w/v)
trichloroacetic acid, and resuspended in distilled water, prior to
protein concentration measurement.
Whole Cell Protein Extract of Conidia
and Hyphae (Total WCP)
To obtain total protein extracts, 5 x 105 cells/ml (conidia or yeasts)
were inoculated into Potato Dextrose Broth (PDB) (Pronadisa,
Madrid, Spain) cultured at 37ºC and 120 rpm for 24 h. Fungal
growth was recovered by filtration and washed twice with PBS to
remove traces from the medium. Fungal material was resuspended
in PBS supplemented with 1% (v/v) b-mercaptoethanol and 1% (v/
v) ampholytes pH 3-10 (GE Healthcare, Freiburg, Germany).
Finally, cell disruption was achieved by bead-beating with glass
beads for 20min at 30Hz using theMillMix20 (Tethnica, Slovenia),
following the standardized protocol described previously (Pellon
et al., 2016). Cell debris was discarded by centrifugation, and the
resulting protein suspension was sonicated on ice for 2 min at 40%
amplitude and 2 s pulses.
Extract of Secreted Proteins (Secretome)
Extraction of S. boydii secretome was carried out following the
methodology described in Buldain et al., 2019, with slight
modifications. Briefly, 106 conidia/ml were inoculated into PDB
and grown for 24 h at 37ºC and 120 rpm. Fungal material was
collected, washed twice with sterile PBS and cultured for 20 h at
37ºC and 120 rpm in PBS supplemented with 2% glucose in a
proportion 1 g fungus: 1 mLmedium. The culture was centrifuged,
the supernatant filtered through a sterile gauze and then through a
0.22 µm membrane. Finally, the cell-free supernatant was
concentrated using a 100,000 MWCO VIVASPIN centrifugal
concentrator system (Sartorius, Göttingen, Germany). The
resulting suspension was sonicated under the same conditions as
the Total WCP extract described above.
Cell Surface Associated Proteins
(Total CSP and Conidial CSP)
Proteins associated with the cell surface were collected by
employing the protocol described by Pitarch et al. (2002), but
with some modifications. To be precise, the culture of 5 x 105
conidia/ml PDB for 24 h at 37ºC and 120 rpm was recovered by
filtration and washed twice with PBS. Fungal material was
resuspended in a volume of SDS extraction buffer and boiled
for 10 min at 100ºC, cooled 5 min on ice, centrifuged and the
supernatant containing Total CSP was recovered.
To obtain the Conidial CSP extract, the same procedure was
carried out but using 108 conidiospores as fungal material, which
were directly resuspended in 1 ml of extraction buffer.
Enzyme Linked Immunosorbent Assay
(ELISA) for the Detection of
Scedosporium/Lomentospora
Specific anti-S. boydii IgG was measured using a customized
enzyme-linked immunosorbent assay (ELISA) method. ELISAFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4was performed by coating wells of high binding micro test plates
(Sarstedt, Nümbrecht, Germany) overnight at 4ºC with 10 µg/ml
of protein extract diluted in sterilized PBS (100 µl per well). The
following day the wells were washed three times with 200 µl PBS
and blocked for 1 h at 37ºC by adding 200 µl of 5% (w/v)
skimmed milk powder solution in PBS containing 0.05% (v/v)
Tween 20 (PBST). Thereafter, three washes with PBST preceded
the incubation at 37ºC for 1 h with 100 µl of human sera diluted
1:200 in PBST. In parallel, PBST without serum was added to
some wells as negative control. Then these plates were washed
three times with PBST, and 100 µl of HRP labeled anti-human-
IgG (Sigma-Aldrich, St. Louis, MO, USA) diluted 1:10,000 in
PBST was added to each well. After 1 h incubation at 37ºC, three
washes with PBS preceded the incubation with 50 µl TMB
substrate solution (Thermo Fisher, Waltham, MA, USA) for
30 min in the dark at 24ºC. Finally, the reaction was stopped by
adding 50 µl of 0.5 M H2SO4 and absorbance (Abs) was
measured at 450 nm using a Synergy TM HT plate reader
(BioTek, Winooski, VT, USA).
A pool made up of the five Scedo+ sera selected was included
in each experiment as a positive control to monitor batch-to-
batch variations and to normalize the data after the study.
Data Processing, Statistical
Treatment, and Analysis
For data analysis, absorbance (Abs) values obtained in negative
control wells were subtracted from remaining wells. Serum
samples were measured in duplicate, and three replicates were
performed for each ELISA experiment. With the aim of avoiding
plate to plate bias variation, each Abs value was divided by the
Abs value of the positive control included in all the plates and the
result was expressed as Relative Abs.
Successive statistical analyses were run in SPSS Statistics
software version 24 (IBM, Armonk, NY, USA) and the data
plotted using Prism7 software (GraphPad, San Diego, CA, USA).
Data distribution and its normality was studied by box plot
analysis (see Supplementary Material 1). Two outlying values,
classified into the Scedo- group, were identified and excluded
from the analysis hereinafter. Normal distribution of data was
detected by the Shapiro-Wilk test (< 50 samples) or the
Kolmogorov-Smirnov test (> 50 samples), and homogeneity of
the variance was proven by Levene test. Mean IgG response was
compared between the three sera groups (Scedo+, Asp+, and
Scedo-/Asp-) by performing a one-way analysis of variance
(ANOVA) for normal distributed data or by Kruskal-Wallis
for data with non-normal distribution, followed by
Bonferroni’s multiple comparison test. Likewise, Scedo+
group’s mean specific IgG response was compared to the mean
response of Scedosporium negative samples (Asp+ and Scedo-/
Asp-) by performing Student’s t test or the Mann-Whitney U test
for data with a normal and non-normal distribution,
respectively. All the analyses were performed taking into
account a confidence interval (CI) of 95%, for this a p-value
< 0.05 was considered statistically significant.
The optimal diagnostic cut-off value to discriminate positive
and negative results was selected by taking into consideration theNovember 2020 | Volume 10 | Article 602089
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et al., 2016; Mina et al., 2017; Unal, 2017): Youden Index (J),
Concordance Probability Method (CZ), Index of Union (IU),
Closest to [0.1] criteria (ER), Control mean Abs plus 2 standard
deviation (SD) (X + 2SD), and Sensitivity = Specificity (SE = SP),
and the maximum positive likelihood ratio (MLR+).
To calculate the cut-off value of Abs by some of these criteria an
analysis of the Receiver Operating Characteristic (ROC) curve was
performed, and the performance of the test was checked based on
the area under theROCcurve (AUC). Todo this, Absobtainedwith
each serum sample of Scedo+ group were considered as Patient
Values, meanwhile Abs of sera fromAsp+ and Scedo-/Asp- groups
were included in Control Values. In this way, the ROC area under
the curve (AUC) was drawn with 95% CI.
Finally, the accuracy and test performance of the ELISA was
evaluated by comparison with the “Gold Standard” method
(mycological culture of the sputa), calculating validation
parameters of Sensitivity (SE), Specificity (SP), Positive
Predictive Value (PPV), Negative Predictive Value (NPV), and
Efficiency (EFF). In addition, agreement between the two
techniques was analyzed by Cohen’s Kappa index (K), which
excludes the possibility of agreement occurring by chance.RESULTS
Fungal Prevalence in CF Patients’
Sputum Samples
The epidemiological study of the group of sera used in this work,
carried out according to the microbiological examination ofFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 5patients’ sputum (Figure 2), showed that Candida yeasts were
detected in 51.43% of the patients, C. albicans being the most
frequently isolated (74.07%). Regarding filamentous fungi,
31.43% of the patients resulted in positive cultures for species
in the genus Aspergillus, A. fumigatus being the most prevalent
(66.67%), followed by Aspergillus terreus (39.39%) and species of
Aspergillus flavus complex (3.03%). Meanwhile, 11.43% of CF
patients were positive for Scedosporium/Lomentospora, with the
highest impact from the S. apiospermum species complex
(83.33%) and a significant prevalence of L. prolificans (50%).
Likewise, 36.19% of the population studied showed negative
cultures for these three fungal pathogens.
Reactivity of Human Sera Against
S. boydii Protein Extracts
With the aim of analysing the immunoreactive capacity and the
discriminatory power of S. boydii protein extracts, specific IgG
reactivity offive sera from different patients selected from each of
the three groups of CF sera were measured by ELISA using four
different types of protein extracts as antigen: Total WCP,
Secretome, Total CSP, and Conidial CSP (Figure 3). In this
sense, all extracts allowed the differentiation of the three groups,
with the differences between Scedo+ and the other two groups,
separately or together, statistically significant. From the four
extracts, the best results were obtained with the Total WCP
(Figure 3A) as discrimination of sera was the most accurate, and
there was no overlap between groups.
Although the secretome extract offered almost as accurate
results, when evaluating the efficiency of the extraction methods
(Figure 4) in terms of processing time, initial culture volumeFIGURE 2 | Frequency of isolation of fungal species from respiratory samples of Cystic Fibrosis (CF) patients when culturing sputum samples on Sabouraud
gentamicin chloramphenicol agar and Modified Thayer Martin agar or Sabouraud chloramphenicol cycloheximide agar for the selective recovery of Scedosporium
species from these polymicrobial samples. The circle depicts the general prevalence of Aspergillus spp., Scedosporium/Lomentospora and Candida spp., as well as
the frequency of patients with negative cultures for these fungi: 31.43%, 11.43%, 51.43%, and 36.19%, respectively. Moreover, the species-specific prevalence is
represented within the boxes.November 2020 | Volume 10 | Article 602089
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secretome extraction method was very time-consuming and
yielded a lower concentration of protein.
IgGs Cross-Reactivity Study With Total
WCP Extract of L. prolificans,
A. fumigatus, and C. albicans
Selected sera were also tested against total WCP extract of the
related species L. prolificans, and the most representative species
of the two genera most frequently isolated in CF, A. fumigatus,
and C. albicans (Figure 5). ELISA values showed that there is a
high cross-reactivity between groups of patients when the
antigens of A. fumigatus and C. albicans are used. Meanwhile,
L. prolificans extract was able to discriminate between groups,
with the differences being statistically significant. This
demonstrates that there is high cross-reactivity between
Scedosporium and Lomentospora because protein extracts of
both fungi succeeded in discriminating Scedo+ patients
(Figure 5A). Moreover, sera from Scedo+ groups seemed to
cross react with Aspergillus extract (Figure 5B), although theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 6contrary was not observed, as sera from Asp + did not detect
Scedo+ extract at the same level (Fig 5A). In the case of the
C. albicans extract, sera from the three groups showed high
reactivity against it (Figure 5C).
Total WCP Extract of S. Boydii as a
Valuable Tool for Serological Detection
of Scedosporium/Lomentospora
In order to evaluate S. boydii Total WCP extract as a
serodiagnostic tool for Scedosporium/Lomentospora detection,
sera from the collection were tested individually using ELISA
(Figure 6).
When plotting all the values obtained in the ELISA assay, the
three categories of sera were well distinguished. Indeed,
differences between the median value of the specific
IgG response for group Scedo+ compared to that obtained for
Asp+ and Scedo-/Asp- were statistically significant, and also
differed significantly from that obtained considering all
Scedosporium negative samples together (Asp+ and Scedo-/
Asp-) (***p < 0.001).A B
DC
FIGURE 3 | Screening of the immunoreactivity of Cystic Fibrosis (CF) patients’ sera against Scedosporium boydii protein extracts. Total WCP (A), Secretome (B),
Total CSP (C), and Conidial CSP (D). Specific IgG antibody response is represented for the five sera selected from each group (Scedo+, Asp+ and Scedo-/Asp-)
and against each protein extract, by relative Abs value at 450 nm obtained for each serum. Wide horizontal lines depict the media, and short horizontal lines
represent the standard deviation (SD). Median value obtained for group Scedo+ is significantly different from that obtained for each of the other two groups, and for
the sum of both (as negative samples) (***p < 0.001; **p < 0.01).November 2020 | Volume 10 | Article 602089
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conducting an ROC analysis that showed an AUC value of
0.9942, meaning a high discrimination capacity (Figure 7).
Nevertheless, to assert whether a result was positive (detection
of Scedosporium/Lomentospora) or negative, a decision threshold
had to be established, so seven different criteria were used: J, CZ,
IU, ER, X + 2SD, SE = SP, MLR+ (Table 1).
According to the above-mentioned criteria, four cut-off values
were identified: Abs450nm > 0.5837 using J, CZ, IU, and ERFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7criteria, and Abs450nm > 0.6042, > 0.6404 and > 0.7099 using SE =
SP, X + 2SD, and MLR+, respectively. When evaluating the test
performance, the SE was ≥ 86.9%, SP ≥ 93.6% and the PVN ≥
98.4% regardless of the cut-off point selected. However, the PPV
suffers a large variation, from 65%–95%, depending on the cut-
off value. The K index was calculated as 0.76, 0.75, and 0.78 for
the 0.5837, 0.6042, and 0.6404 cut-offs respectively, indicating a
substantial agreement excluding chance. For the 0.7099 cut-off
the K index calculated was 0.89 which indicates an almost perfect
agreement. The cut-offs and the corresponding validation
parameters are detailed in Table 1.
Monitoring of Specific IgG Levels
Against Scedosporium
In order to determine the utility of the designed serological test, not
only for serodiagnosis using a single sample point but also in the
monitoring of CF patients, the Abs value of several serum samples
corresponding to the same patient were plotted in a time-dependent
manner according to the date of sample. Themonitoring of patients
(P) with at least three serum samples obtained over a period of
more than 15 days is shown in Figure 8 and distributed in three
different graphs according to the CF group in which they were
previously classified. In this way, the evolution of the humoral IgG
specific response against S. boydii can be observed and therefore,
the evolution of the disease. In fact, some interesting trends where
found when looking at the patients represented.
Scedo+ monitored patients (Figure 8A) showed a high
specific IgG response, which in all cases exceeded the cut-off
values determined in this study. Specifically, P1 and P2 showed
values that remained stable as clearly positive over the sampling
interval. Conversely, P3 experienced an initial period of stability,
but the final sample value decreased and crossed the threshold
towards a negative outcome, and therefore, suggests a possible
clinical improvement that should be confirmed with subsequent
additional samples.FIGURE 4 | Evaluation of the efficiency of the methods for obtaining the
different protein extracts of S. boydii. Approximate performance values of
extraction methods: time of procedure, final volume of useful extract, protein
concentration, and quality of the extract.A B C
FIGURE 5 | Immunoreactivity of CF patients’ serum IgGs to other fungal pathogens. Immunoreactivity of specific serum IgG against Total CWP of L. prolificans (A),
A. fumigatus (B), and C. albicans (C) is represented as the relative Abs value at 450 nm obtained for each serum. Wide horizontal lines depict the median, and short
horizontal lines represent the interquartile range (IQR), except for graph A where media (SD) is represented. Comparison of the median value among Scedo+ group
and each of the other two groups, and for the sum of both as negative samples (**p < 0.01; *p <0.05).November 2020 | Volume 10 | Article 602089
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serological profiles plotted corresponded to representative
patients from the group, whose values were clearly under the
diagnostic threshold. Nevertheless, two of the monitored patients
showed a fairly high humoral response. P6 was close to the cut-
off, even in certain sample times that crossed the threshold, whileFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8P5 exhibited a serological response that matches the profile of
culture-confirmed Scedo+ patients. In this sense, these patients
should remain under surveillance since they are at risk of
presenting an undiagnosed Scedosporium colonization.
Finally, the monitoring of the patients from the Scedo-/Asp-
group is illustrated in Figure 8C. Although most of the patients
maintained negative results during the sampling period, P1, P2,
and P3 showed intriguing serological profiles due to the high
values detected. While P6 started with values close to the
threshold but eventually developed a downward trend, P2 and
P3 started the sampling with clearly negative results, however,
high positive values were obtained in later samples. Which in
turn, indicates that these patients, and especially P3, need to be
carefully monitored since they may have an undetected presence
of Scedosporium.DISCUSSION
The range of fungal species detected in CF patients continues to
increase in line with new discoveries in diagnostic methodologies
(Tracy & Moss, 2018). The development of selective culture
media has become a cornerstone for improving the classic gold
standard of culture-based diagnosis, enhancing the recovery of
low prevalence and/or slow growing fungal pathogens (Pham
et al., 2015; Hong et al., 2017; Coron et al., 2018). However, there
are still huge limitations that hinder the correct detection of theseFIGURE 6 | IgG response against Scedosporium boydii Total WCP extract of cystic fibrosis patients. Patients with positive sputum cultures for Scedosporium/
Lomentospora are classified into group Scedo+, with positive cultures for Aspergillus spp. into group Asp+, and cultures without any recovery of these fungi into
group Scedo-/Asp-. Antibody responses are represented by the relative Abs value at 450 nm obtained for each serum. The four cut-off values obtained are depicted
as solid, dotted and dashed lines. Wide horizontal lines depict the median, and short horizontal lines represent the interquartile range (IQR). Median value obtained
for group Scedo+ is significantly different from that obtained for each of the other two groups, and for the sum of both (as negative samples) (***p < 0.001).FIGURE 7 | Receiving operating characteristics curve (ROC) for anti –
Scedosporium boydii Total WCP IgG ELISA. Scedo+ patients vs. negative
patients (Asp+ and Scedo-/Asp-). The area under the curve (AUC) for S. boydii-
specific IgG was 0.9924. Line of identity is indicated with the dashed line.November 2020 | Volume 10 | Article 602089
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respiratory samples and the absence of commercial available
culture media designed for these challenging isolations (Chen
et al., 2017). On the other hand, serological tests have led to non-
culture-based diagnosis of fungal infections since the 1950s
because of their advantages, such as the ease of minimally
invasive sample collection (Richardson and Page, 2018).
Unfortunately, at present, there is a lack of specific serological
kits for low-prevalence fungal pathogens that enable rapid and
easy detection.
For many years, efforts have been focused on Aspergillus
fumigatus as it is the most prevalent filamentous fungi in CF
airways (Richardson & Page, 2017). In this sense, crude antigenic
extracts from conidia and hyphae have been widely used for
Aspergillus serological detection (Page et al., 2016). On the other
hand, species from Scedosporium genus are gaining more and
more attention because of their high chronicity in CF airways as
well as their associated pathogenicity. However, despite their
disturbing clinical relevance, accurate detection methods that
allow an adequate diagnosis of these threatening pathogens is
currently lacking (Chen et al., 2017). Mycological culturing
continues to be the most widespread method. This requires the
use of selective media that are not available everywhere, and
incubation times for these slow-growers are excessively long
(Coron et al., 2018). This problem is reflected in the
epidemiological studies that suffer worrying variations in theFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 9prevalence rates, caused to some extent, by the use of different
and non-standardized procedures. In fact, there is a growing
awareness of this issue and this has led to the publication of
research into the frequency variation depending on the detection
method employed (Borman et al., 2010; Sedlacek et al., 2015;
Hong et al., 2017; Boyle et al., 2018; Hedayati et al., 2019). These
diagnostic hurdles in turn result in delayed diagnosis, and
consequently, a late introduction of an effective treatment.
Therefore, considering the mounting concern about the critical
need for standardized and reliable detection methods, efforts
must be made to develop rapid and robust tests to ensure an early
detection of Scedosporium, and consequently the establishment
of an effective treatment and patient monitoring. With this in
mind, the aim of this study was to analyse the utility of different
protein extracts of S. boydii for a serological detection of
Scedosporium/Lomentospora in CF patients by ELISA.
To achieve this, 212 serum samples corresponding to 105 CF
patients were used. Patients were classified into three groups,
Scedo+, Asp+, and Scedo-/Asp-, based on the fungus isolated from
the sputum, Scedosporium, Aspergillus, or neither, respectively.
Mycological cultures showed that Candida was the most
frequently isolated fungus among yeasts, and Aspergillus among
filamentous fungi. Nevertheless, Scedosporium species were
isolated from 11.43% of CF patients’ sputa, these results were in
agreement with the prevalence rates of 8%–16% published in
different epidemiological studies (Cimon et al., 2000; Blyth et al.,TABLE 1 | Performance of Scedosporium boydii specific IgG at different cut-off values with 25 serum samples of Cystic Fibrosis patients with Scedosporium/
Lomentospora positive sputum cultures and 190 negative sera.
Cut-off value (Relative A450nm) Criteria Test validation parameters (%)
SE SP EFF PPV* NPV* K
0.5837 J, CZ, IU, ER 100 93.58 94.29 65.71 100 0.76
0.6042 SE=SP 95.65 94.12 94.29 66.67 99.44 0.75
0.6404 (X + 2SD) 91.30 95.72 95.24 72.41 98.90 0.78
0.7099 MLR+ 86.96 99.47 98.10 95.24 98.41 0.89November 2020 | Volume 10 | Article 60J, Youden Index; CZ, Concordance Probability Method; IU, Index of Union; ER, Closest to [0,1]; X, mean value of control sera absorbance; SD, standard deviation; MLR+, maximum
positive likelihood ratio; SE, sensitivity; SP, specificity; EFF, efficiency or correct classification rate; PPV, predictive value of positive test; NPV, predictive value of negative test; K, Cohen’s
Kappa index.
(*) Theoretical values considering a prevalence of Scedosporium/Lomentospora of 11.43% observed in this study.A B C
FIGURE 8 | Monitoring of specific IgG serological response of CF patients against S. boydii. Example of representative patients of the Scedo+ group (A), Asp+
group (B), and Scedo-/Asp- group (C). Relative Abs values of the ELISA test using a total WCP of S. boydii are depicted on a time scale.2089
Martin-Souto et al. Scedosporium/Lomentospora Serodiagnosis in Cystic Fibrosis2010; Schwarz et al., 2017). Moreover, species of S. apiospermum
complex were isolated in 85.33% of Scedo+ patients, which is
consistent with the Scedosporium species distribution in CF, since
S. apiospermum and S.boydii are the most frequently isolated
species (Bouchara et al., 2019). Finally, L. prolificans was detected
in 50% of Scedo+ patients, which is a notoriously high prevalence
rate when compared with the worldwide incidence data (0%–
40%), but it is in concert with the geographical restriction of the
fungus, Spain and Australia being the countries with the highest
incidence (Seidel et al., 2019).
The first step in the design of the ELISA for the serological
detection of Scesdosporium/Lomentospora was the selection of an
easy-to-obtain protein extract with a good level of
discrimination. Some research has deciphered potential
Scedosporium virulence markers (reviewed in Santos et al.,
2009) with different cellular locations that are related to both
morphological phases (hypha and conidium). Bearing in mind
the wide variety of antigens, the immunoreactivity and
discriminatory capacity of four S. boydii protein extracts, which
included total protein extract (Total WCP), secretome extract,
cell surface associated proteins (Total CSP), and cell surface
associated proteins only from conidia (Conidia CSP), were
compared by indirect ELISA against fifteen patients (five
from each CF group). The results obtained with the four extracts
showed that they were able to discriminate Scedo+ sera from Asp+
and Scedo-/Asp- groups. However, of the four extracts, Total WCP
was selected to continue with the study as it was the one with the
highest output in terms of protein concentration per mL of fungal
culture used, and the discriminatory capacity was the best because
none of the five patients tested in the Scedo+ group overlapped with
any of the other two groups.
Among the discarded extracts, secretome was expected to be
interesting because of the chronicity of Scedosporium colonizations
of CF airways and the specificity of the secreted proteins according
to bibliography (Santos et al., 2009; Bertrand et al., 2010).
Moreover, metalloproteases such as superoxide dismutase, some
proteolytic enzymes, as well as ectophosphatases are secreted to the
external environment and play a protective role for the fungus and
orchestrate the cleavage of key host components (Larcher et al.,
1996; Da Silva et al., 2006; Da Silva et al., 2012). In agreement with
this idea, the results obtained using this extract were very good, but
similar to the ones obtained with the Total WCP and, additionally,
there were some problems with gathering high protein
concentrations, a long and complex process was necessary to
obtain an extract with low yields.
Regarding Total CSP and Conidial CSP, it is well known that
some cell wall associated proteins of Scedosporium, such as
glucans, peptidorhamnomanns and glucosylceramides, show a
high immunoreactive capacity (Pinto et al., 2004; Da Silva Xisto
et al., 2019). Moreover, since the typical entry of the fungus into
the host body is through inhalation of conidia, it is reasonable for
proteins of the cell wall of the conidium to play an important role
in the host-pathogen interactions and colonization/infection of
airways (Buldain et al., 2016). Consequently, as with the
secretome, the results obtained were also good but yielded low
protein concentration and in addition, some overlappingFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10between groups with the Conidial CSP was observed. This
cross-reactivity could be explained by the fact that some
surface proteins of the conidia are common to different
moulds, are important for the survival of the fungus, and
possess immune-modulatory functions (Voltersen et al., 2018).
Hence, further experiments were carried out using Total
WCP. Crude antigenic extracts have been widely used in
immunodiagnostic systems, some of them being currently
commercially available for the detection of Aspergillus (Page
et al., 2016; Richardson and Page, 2017). The advantage of these
kinds of extract is that they involve every interesting antigen. On
the contrary, one of their main handicaps is their cross-reactivity
against panfungal antigens of closely related fungi (Buldain et al.,
2019). In this sense, biochemical studies try to characterize
specific proteins for diagnostic purposes, but as little is known
about the physiology and biochemistry of Scedosporium, and the
number of studies performed in the field is small, only a few
proteins of interest have been characterized. Among these are a
serine protease from the subtilisin family, two enzymes involved
in ROX detoxification, cytosolic Cu,Zn-superoxide dismutase, a
catalase and some heat shock proteins (Santos et al., 2009).
Moreover, the potential of crude antigenic extracts of
Scedosporium/Lomentospora, which is the first step in the
serodiagnosis race, has not yet been evaluated. In this way,
Total WCP was tested against the totality of sera by the same
optimized ELISA assay, and the results show that it was able to
discriminate the Scedo+ patients successfully. In this sense, ROC
AUC analysis possesses a good discriminatory capacity for the
test (AUC=0.9942) but assessing the criteria for cut-off
determination (Habibzadeh et al., 2016; Unal, 2017), four
threshold values were represented. The most affected
parameter was the theoretical PPV*, because a PPV* of 65%
was obtained with the lowest threshold values but it increased to
95% in the highest one. Theoretical NPV*, efficiency and
specificity values remained more or less stable in all the cases,
while sensitivity varied from 86%–100% with the highest and the
lowest cut-offs, respectively. Despite the variations observed, the
ELISA assay showed a remarkably high specificity, which means
an absolute capacity to discriminate CF patients with no
presence of Scedosporium. Moreover, it was observed that
being stricter with the selection of the cut-off value resulted in
improved ability to detect Scedosporium positive patients.
Nevertheless, choosing one cut-off value may be risky
considering the limited number of Scedo+ samples. In this
sense, increasing this sample population might be helpful to
establish a definitive cut-off point.
Turning to the commercial kits for Aspergillus detection that
show a 75%–96% sensitivity (Richardson and Page, 2017), the
developed test exhibits a remarkable clinical usefulness
considering that values of 86 - 100% of sensitivity and 93%–
99% of specificity were obtained. Moreover, it is worth
mentioning that Lomentospora- positive culture patients also
showed a specific response against S. boydii extract, so the
developed ELISA platform is a valuable tool to detect the
intrinsic multi-resistant fungus L. prolificans as well. In the last
few years, other authors have made efforts to shed light onNovember 2020 | Volume 10 | Article 602089
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in 2017 developed an ELISA with two recombinant proteins,
Scedosporium catalase A1 and cytosolic Cu,Zn-superoxyde
dismutase, described as antigens with diagnostic utility in
Aspergillus. In this study, they managed to detect Scedosporium
infections, and differentiate it from an Aspergillus infection.
Moreover, precipitin assays can be performed but they take up
to one week for the results to be obtained, lack sensitivity
(Fujiuchi et al., 2016), and can only be performed in a few
specialized laboratories (Cimon et al., 2000).
Finally, the study of the ELISA test as a patients’ monitoring
tool showed the value of the technique for the observation of the
evolution of the fungal presence since the humoral response of
the patient can be tracked over time, although this point should
be studied in more depth in the future. Nevertheless, the best
diagnosis is the variety of tests with different purposes that
complement each other and offer a real vision of the patient’s
condition and evolution. In this sense, our research group aimed
to explore new diagnostic resources by developing an indirect
ELISA test using S. boydii whole cell protein extract. Detecting
humoral response against Scedosporium in CF patients regardless
the result of the culture may be helpful for clinicians to maintain
these patients under surveillance, and to anticipate the
establishment of their antifungal treatment.CONCLUSIONS
In this study a crude antigenic extract of S. boydii was selected to
detect Scedosporium/Lomentospora serologically. The ELISA test
developed is able to detect the Scedosporium spp. and L.
prolificans in CF patients’ sera, with a very high sensitivity and
specificity, up to 100% and 99%, respectively. Thus, this ELISA
platform offers a rapid, low-cost and easy solution to detect these
elusive fungi through minimally invasive sampling, with high
output and specificity, and allows the monitoring of the
evolution of the infection, the recovery and the effectiveness of
the antifungal therapy. In spite of the potential of these results,
more research is needed in this field to detect specific antigens
from the fungal extract to improve sensitivity and specificity, to
minimize cross-reactivity with other closely related fungal
pathogens, and ultimately to reach a standardized method.
Nevertheless, it is worth bearing in mind that the best
diagnosis is achieved with a combination of methods that
allow a complete vision of the infection.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11DATA AVAILABILITY STATEMENT
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